Search results for "table"

showing 10 items of 2807 documents

Effect of thickener on disintegration, dissolution and permeability of common drug products for elderly patients

2019

Dysphagia is a very common problem suffered by elderly patients. The use of thickeners during administration in these patients helps to prevent difficulties with swallowing larger solid dosage forms. However, there are several indications when the thickeners may influence disintegration and dissolution processes of solid dosage forms, potentially affecting therapeutic efficacy. In this paper the effects of a commonly used thickener on tablet disintegration, dissolution and subsequent absorption of 6 formulated drugs frequently used in elderly patients (Aspirin, Atenolol, Acenocumarol, Candesartan, Ramipril and Valsartan) in two different administration conditions (intact tablet and crushed …

DrugDrug Compoundingmedia_common.quotation_subjectPharmaceutical Science02 engineering and technologyPharmacology030226 pharmacology & pharmacyPermeabilityDosage form03 medical and health sciences0302 clinical medicinemedicineAnimalsHumansIn patientDissolution testingRats WistarDissolutionAgedmedia_commonViscosityChemistryGeneral Medicine021001 nanoscience & nanotechnologyAtenololRatsDrug LiberationSolubilityPermeability (electromagnetism)Deglutition Disorders0210 nano-technologyTabletsBiotechnologymedicine.drugEuropean Journal of Pharmaceutics and Biopharmaceutics
researchProduct

Aloin delivery on buccal mucosa: ex vivo studies and design of a new locoregional dosing system

2014

Context: Chemoprevention of potential malignant disorders or cancerous lesions that affect oral mucosae requires extended duration of treatment. Locoregional delivery of natural products could represent a promising strategy for this purpose. Objective: To investigate the aptitude of aloin to permeate through, or accumulate in, the buccal mucosa and to develop a new prolonged oro-mucosal drug delivery system. Materials and Methods: Permeation/accumulation of aloin from Curacao Aloe (containing 50% barbaloin) was evaluated ex vivo, using porcine buccal mucosa as the most useful model to simulate human epithelium. Oro-mucosal matrix tablets were prepared by dispersing aloin (10% w/w) in Eudrag…

DrugEmodinPolymersSwinemedia_common.quotation_subjectChemistry PharmaceuticalAcrylic ResinsPharmaceutical ScienceDentistryAloinPharmacologyFriabilityPermeabilityBarbaloin buccal tablets aloin matrix tablets oro-mucosal delivery locoregional drug delivery buccal mucosa.chemistry.chemical_compoundDrug Delivery SystemsSettore MED/28 - Malattie OdontostomatologicheDrug DiscoverymedicineAnimalsDosingAloemedia_commonPharmacologybusiness.industryOrganic ChemistryMouth MucosaAdhesivenessReproducibility of ResultsPermeationDrug LiberationchemistrySettore CHIM/09 - Farmaceutico Tecnologico ApplicativoDrug deliverySwellingmedicine.symptombusinessEx vivoTablets
researchProduct

Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Enalapril

2018

Literature data relevant to the decision to allow a waiver of in vivo bioequivalence testing for the marketing authorization of immediate-release, solid oral dosage forms containing enalapril maleate are reviewed. Enalapril, a prodrug, is hydrolyzed by carboxylesterases to the active angiotensin-converting enzyme inhibitor enalaprilat. Enalapril as the maleate salt is shown to be highly soluble, but only 60%-70% of an orally administered dose of enalapril is absorbed from the gastrointestinal tract into the enterocytes. Consequently, enalapril maleate is a Biopharmaceutics Classification System class III substance. Because in situ conversion of the maleate salt to the sodium salt is sometim…

DrugEnalaprilatmedia_common.quotation_subjectAdministration OralPharmaceutical ScienceAngiotensin-Converting Enzyme InhibitorsBioequivalencePharmacology030226 pharmacology & pharmacyPermeabilityDosage form03 medical and health sciences0302 clinical medicineDrug StabilityEnalaprilmedicineHumansProdrugsEnalaprilmedia_commonChromatographyChemistryProdrugBiopharmaceutics Classification SystemIntestinal AbsorptionSolubilityTherapeutic EquivalencyEnalapril Maleate030220 oncology & carcinogenesisTabletsmedicine.drugJournal of Pharmaceutical Sciences
researchProduct

Biowaiver Monographs for Immediate-Release Solid Oral Dosage Forms: Nifedipine

2015

Literature data relevant to the biopharmaceutical properties of the active pharmaceutical ingredient (API) nifedipine are reviewed to evaluate whether a waiver of in vivo bioequivalence (BE) testing of immediate-release (IR) dosage forms formulated as tablets and soft gelatin capsules is warranted. Nifedipine's solubility and permeability, its therapeutic use and index, pharmacokinetics, food drug interactions, and any reported BE/bioavailability problems were all taken into consideration. Solubility and BA data indicate conclusively that nifedipine is a class II substance of biopharmaceutics classification system (BCS) and that the formulation of drug product plays a key role on the dissol…

DrugNifedipineChemistry Pharmaceuticalmedia_common.quotation_subjectPharmaceutical ScienceCapsulesBioequivalencePharmacologyDosage formExcipientsFood-Drug InteractionsNifedipinePharmacokineticsmedicineAnimalsHumansmedia_commonActive ingredientChemistryCalcium Channel BlockersBiopharmaceutics Classification SystemBioavailabilityIntestinal AbsorptionSolubilityTabletsmedicine.drugJournal of Pharmaceutical Sciences
researchProduct

Isosorbide dinitrate: pharmacokinetics after intravenous administration.

1982

Isosorbide dinitrate (ISDN) is an important organic nitrate found therapeutically useful in its sublingual and oral forms in various cardiovascular diseases such as angina pectoris (1) and congestive heart failure (2). Recently Distante et al. (3) showed that an intravenous infusion of this drug, at 0.021–0.083 mg/min is also effective in managing unstable angina. The availability of an intravenous dosage form of ISDN not only affords the opportunity to characterize the pharmacokinetics of this drug after this particular mode of therapy, but also gives the possibility of assessing the bio-availability of this drug after other (e.g., oral) routes of administration in patients. This latter po…

DrugUnstable anginabusiness.industrymedia_common.quotation_subjectPharmaceutical ScienceIsosorbide Dinitratemedicine.diseaseDosage formAngina PectorisAnginaKineticsPharmacokineticsHeart failureAnesthesiamedicineHumansIn patientInfusions ParenteralIsosorbide dinitratebusinessmedia_commonmedicine.drugJournal of pharmaceutical sciences
researchProduct

Aerosolized GLP-1 for Treatment of Diabetes Mellitus and Irritable Bowel Syndrome

2014

Diabetes is a global burden and the prevalence of the disease, in particular diabetes mellitus type 2 is rapidly increasing worldwide. After introduction of insulin into clinical therapy about 90 years ago a major number of pharmaceuticals has been developed for treatment of diabetes mellitus type 2. One of these, the incretin glucagon-like peptide 1 (GLP-1), like insulin, needs subcutaneous administration causing inconvenience to patients. However, administration of GLP-1 plays also a role for treatment of irritable bowel syndrome (IBS). To improve patient convenience inhaled insulin (Exubera®) was developed and approved but failed market acceptance some years ago. Recently, another inhala…

Drugendocrine systemmedicine.medical_specialtyInhalationbusiness.industrymedia_common.quotation_subjectInsulinmedicine.medical_treatmentdigestive oral and skin physiologyIncretinDiseasemedicine.diseaseGlucagon-like peptide-1Diabetes mellitusInternal medicinemedicinebusinesshormones hormone substitutes and hormone antagonistsIrritable bowel syndromemedia_common
researchProduct

Biowaiver monograph for immediate-release solid oral dosage forms: acetylsalicylic acid.

2012

A biowaiver monograph for acetylsalicylic acid (ASA) is presented. Literature and experimental data indicate that ASA is a highly soluble and highly permeable drug, leading to assignment of this active pharmaceutical ingredient (API) to Class I of the Biopharmaceutics Classification System (BCS). Limited bioequivalence (BE) studies reported in the literature indicate that products that have been tested are bioequivalent. Most of the excipients used in products with a marketing authorization in Europe are not considered to have an impact on gastrointestinal motility or permeability. Furthermore, ASA has a wide therapeutic index. Thus, the risks to the patient that might occur if a nonbioequi…

Drugmedia_common.quotation_subjectPharmaceutical ScienceAdministration OralBiological AvailabilityPharmacologyBioequivalenceMarketing authorizationDosage formDrug StabilityFibrinolytic AgentsAnimalsHumansCyclooxygenase Inhibitorsmedia_commonActive ingredientAspirinChemistryAnti-Inflammatory Agents Non-SteroidalBiopharmaceutics Classification SystemSolubilityTherapeutic EquivalencyPlatelet aggregation inhibitorCaco-2 CellsFibrinolytic agentPlatelet Aggregation InhibitorsTabletsJournal of pharmaceutical sciences
researchProduct

A Branch-and-Cut method for the Capacitated Location-Routing Problem

2011

International audience; Recent researches in the design of logistic networks have shown that the overall distribution cost may be excessive if routing decisions are ignored when locating depots. The Location-Routing Problem (LRP) overcomes this drawback by simultaneously tackling location and routing decisions. The aim of this paper is to propose an exact approach based on a Branch-and-Cut algorithm for solving the LRP with capacity constraints on depots and vehicles. The proposed method is based on a zero-one linear model strengthened by new families of valid inequalities. The computational evaluation on three sets of instances (34 instances in total), with 5–10 potential depots and 20–88 …

Dynamic Source RoutingMathematical optimizationGeneral Computer ScienceComputer scienceEqual-cost multi-path routingRouting tableTesting0211 other engineering and technologiesGeographic routingLogistics02 engineering and technologyManagement Science and Operations ResearchBranch and CutSimulated annealingStochastic processesBranch-and-CutLocation-RoutingVehicle routing problem0202 electrical engineering electronic engineering information engineeringFacility locationDestination-Sequenced Distance Vector routingRoutingMathematicsStatic routing021103 operations researchLocation routingLower BoundLinear modelVehiclesIterative algorithms[INFO.INFO-RO]Computer Science [cs]/Operations Research [cs.RO]Facility location problemVehicle routingCostsLocation-Routing ProblemLink-state routing protocolLagrangian functionsModeling and SimulationMultipath routing020201 artificial intelligence & image processingFittingRouting (electronic design automation)Branch and cutDrawback
researchProduct

Logic-Based Distributed Routing for NoCs

2008

The design of scalable and reliable interconnection networks for multicore chips (NoCs) introduces new design constraints like power consumption, area, and ultra low latencies. Although 2D meshes are usually proposed for NoCs, heterogeneous cores, manufacturing defects, hard failures, and chip virtualization may lead to irregular topologies. In this context, efficient routing becomes a challenge. Although switches can be easily configured to support most routing algorithms and topologies by using routing tables, this solution does not scale in terms of latency and area. We propose a new circuit that removes the need for using routing tables. The new mechanism, referred to as logic-based dis…

Dynamic Source RoutingZone Routing ProtocolStatic routingbusiness.industryComputer scienceRouting tablePolicy-based routingLink-state routing protocolHardware and ArchitectureMultipath routingHardware_INTEGRATEDCIRCUITSDestination-Sequenced Distance Vector routingbusinessComputer networkIEEE Computer Architecture Letters
researchProduct

STUDY ON THE TUNNEL PASTEURIZER ON TABLE OLIVES PROCESSING

2015

The application of heat treatment is particularly important in maintaining the organoleptic characteristics of fermented agro-food products, which potential consumers perceive as reflecting the quality of these foodstuffs. However, heat treatments can be cause of deterioration of many quality parameters of agro-food products, including texture, intended as the consistency of the pulp. In this study 'Nocellara del Belice' table olives produced in 2010 and packaged in glass jars were subjected to pasteurization at industrial scale using a tunnel pasteurizer with a core temperature of 75°C for 8 min. The aim of the study was to mechanically evaluate the pulp texture evolution that contributes …

DynamometerTable oliveTunnel pasteurizerSettore AGR/09 - Meccanica AgrariaTable (landform)HorticultureFlesh firmneMathematicsMarine engineeringActa Horticulturae
researchProduct